XNASISRG
Market cap186bUSD
Dec 20, Last price
524.43USD
1D
0.10%
1Q
7.86%
Jan 2017
644.29%
Name
Intuitive Surgical Inc
Chart & Performance
Profile
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
IPO date
Jun 13, 2000
Employees
12,120
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 7,124,100 14.49% | 6,222,200 8.97% | 5,710,100 31.01% | |||||||
Cost of revenue | 3,393,400 | 2,905,200 | 2,422,600 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 3,730,700 | 3,317,000 | 3,287,500 | |||||||
NOPBT Margin | 52.37% | 53.31% | 57.57% | |||||||
Operating Taxes | 141,600 | 262,400 | 162,200 | |||||||
Tax Rate | 3.80% | 7.91% | 4.93% | |||||||
NOPAT | 3,589,100 | 3,054,600 | 3,125,300 | |||||||
Net income | 1,798,000 35.98% | 1,322,300 -22.43% | 1,704,600 60.72% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (120,000) | (2,373,600) | 64,900 | |||||||
BB yield | 0.10% | 2.47% | -0.05% | |||||||
Debt | ||||||||||
Debt current | 24,200 | 20,400 | ||||||||
Long-term debt | 129,000 | 139,200 | 174,000 | |||||||
Deferred revenue | 45,600 | 41,000 | 36,800 | |||||||
Other long-term liabilities | 275,400 | 398,300 | (123,800) | |||||||
Net debt | (7,214,200) | (9,201,700) | (12,840,600) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,813,800 | 1,490,800 | 2,089,400 | |||||||
CAPEX | (1,064,200) | (532,400) | (353,500) | |||||||
Cash from investing activities | (360,100) | 1,370,800 | (2,461,500) | |||||||
Cash from financing activities | (287,600) | (2,572,300) | 43,000 | |||||||
FCF | 1,470,600 | 2,452,200 | 2,895,000 | |||||||
Balance | ||||||||||
Cash | 5,223,200 | 6,741,500 | 8,619,500 | |||||||
Long term investments | 2,120,000 | 2,623,600 | 4,415,500 | |||||||
Excess cash | 6,986,995 | 9,053,990 | 12,749,495 | |||||||
Stockholders' equity | 4,820,900 | 3,408,700 | 4,787,500 | |||||||
Invested Capital | 8,961,900 | 7,701,600 | 7,130,300 | |||||||
ROIC | 43.08% | 41.19% | 46.41% | |||||||
ROCE | 27.07% | 30.04% | 27.58% | |||||||
EV | ||||||||||
Common stock shares outstanding | 357,400 | 362,000 | 365,800 | |||||||
Price | 337.36 27.14% | 265.35 -26.15% | 359.30 31.76% | |||||||
Market cap | 120,572,464 25.52% | 96,056,700 -26.92% | 131,431,940 33.55% | |||||||
EV | 113,447,964 | 86,925,700 | 118,641,740 | |||||||
EBITDA | 4,152,500 | 3,682,800 | 3,597,700 | |||||||
EV/EBITDA | 27.32 | 23.60 | 32.98 | |||||||
Interest | 29,700 | |||||||||
Interest/NOPBT | 0.90% |